---
title: "INNOSTIC: Currently not engaged in the business of testing reagents related to Chikungunya fever symptoms"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/260828745.md"
description: "On October 13th, INNOSTIC stated on the interactive platform that the company currently does not have a business related to testing reagents for symptoms of Chikungunya fever"
datetime: "2025-10-13T04:09:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/260828745.md)
  - [en](https://longbridge.com/en/news/260828745.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/260828745.md)
---

# INNOSTIC: Currently not engaged in the business of testing reagents related to Chikungunya fever symptoms

On October 13th, INNOSTIC stated on the interactive platform that the company currently does not have any business related to testing reagents for symptoms of Chikungunya fever

### Related Stocks

- [301584.CN](https://longbridge.com/en/quote/301584.CN.md)

## Related News & Research

- [BYD Fang Cheng Bao hits 400,000 sales milestone despite production snags](https://longbridge.com/en/news/287011931.md)
- [Fang Cheng Bao SUV delivery delays highlight BYD's manufacturing pressure amid tech transition](https://longbridge.com/en/news/286999045.md)
- [Goldman Sachs set to be named lead left underwriter for SpaceX IPO, source says](https://longbridge.com/en/news/286975906.md)
- [Market Chatter: Intel Urges PC Makers to Adopt Advanced CPUs Amid Supply Crunch](https://longbridge.com/en/news/286955059.md)
- [EXCLUSIVE: Google's AI Monetization Strategy May Be Leaving Rivals Behind, Says Direxion](https://longbridge.com/en/news/286919559.md)